Melanotan II is a synthetic cyclic peptide analog of alpha-melanocyte-stimulating hormone (α-MSH), a naturally occurring neuropeptide derived from the precursor protein proopiomelanocortin (POMC). Produced through solid-phase peptide synthesis, it is classified as a non-selective melanocortin receptor agonist — meaning it binds to and activates multiple receptor subtypes within the melanocortin system. This broad receptor activity, combined with its structural stability relative to native α-MSH, makes Melanotan II a frequently used tool compound in preclinical and in vitro research settings where melanocortin signaling is under investigation.
Molecular Structure and Key Properties
Melanotan II carries the sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH₂, a seven-amino-acid cyclic structure with an N-terminal acetyl group and a C-terminal amide. The cyclic configuration — formed by a lactam bridge between the aspartic acid and lysine residues — constrains the peptide into a fixed conformation. This structural rigidity is significant in a laboratory context because it limits the conformational flexibility that typically makes linear peptides vulnerable to enzymatic degradation. Compared to α-MSH, Melanotan II demonstrates greater resistance to proteolytic breakdown in biological media, which makes it a more tractable research tool for assays involving cell culture systems or tissue preparations. Its molecular weight is approximately 1024 Da, and it is typically supplied as a lyophilized white powder with solubility in aqueous buffers and dilute acetic acid solutions.
Research Applications
The primary research interest in Melanotan II centers on its activity at melanocortin receptor subtypes — particularly MC1R, MC3R, MC4R, and MC5R. These receptors are G protein-coupled receptors (GPCRs) that signal through cyclic AMP pathways, and each subtype is expressed across different tissue types, from skin and adrenal tissue to hypothalamic and limbic brain regions. In vitro binding studies use Melanotan II to characterize receptor affinity and selectivity profiles, often in competition assays against radiolabeled or fluorescently tagged ligands.
In preclinical rodent models, researchers have used Melanotan II to probe the role of central melanocortin signaling in energy homeostasis research, examining how MC4R activation in hypothalamic circuits affects food intake behavior and metabolic readouts. Separate lines of investigation have used the compound in models examining pigmentation biology, where MC1R-mediated signaling in melanocytes is studied through melanin synthesis assays and downstream cAMP quantification. Additional preclinical work has examined MC3R and MC5R activity in the context of immune cell function and exocrine gland physiology, respectively, using Melanotan II as a pharmacological tool to stimulate receptor pathways and observe downstream protein expression or cellular responses.
Analytical Use and Sourcing Considerations
In laboratory practice, Melanotan II is typically reconstituted from lyophilized form in sterile water or a dilute acetic acid solution, then aliquoted and stored at -20°C or below to minimize degradation. Repeated freeze-thaw cycles reduce peptide integrity over time, so single-use aliquots are standard practice in most research protocols. Working solutions should be prepared fresh where assay sensitivity demands it.
Purity is a critical sourcing variable. For receptor binding studies and cell-based assays, researchers generally require material with HPLC purity of 98% or greater, as lower-purity preparations introduce ambiguity in observed biological responses. Reputable suppliers provide certificates of analysis that include HPLC chromatograms, mass spectrometry confirmation of molecular identity, and residual solvent or counterion data. Mass spectrometry — typically ESI-MS or MALDI-TOF — serves as the standard identity confirmation method given the peptide’s well-characterized molecular weight. Procurement staff should request lot-specific documentation rather than generic product specifications, and should verify that synthesis and quality control are performed under documented, traceable processes consistent with research-grade standards.
Melanotan II continues to attract research interest because of the broad physiological distribution of melanocortin receptors and the compound’s utility as a stable, well-characterized agonist tool for dissecting receptor subtype-specific signaling in controlled experimental systems.
For Research Use Only. Not for human consumption. All compounds described in this article are supplied as analytical-grade reagents for institutional in vitro laboratory research only. Not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
